2696 — Shanghai Henlius Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- HK$8.02bn
- HK$11.39bn
- CNY5.39bn
- 39
- 48
- 81
- 60
Annual cashflow statement for Shanghai Henlius Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -875 | -994 | -957 | -694 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 197 | 133 | 336 | 299 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 152 | 116 | 511 | 1,099 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -443 | -610 | 90.4 | 982 | — |
| Capital Expenditures | -501 | -557 | -1,131 | -1,365 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -632 | -955 | -550 | 6.56 | — |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,133 | -1,512 | -1,681 | -1,359 | — |
| Financing Cash Flow Items | -53 | -54.7 | -83.4 | -115 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,948 | 996 | 648 | 858 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,342 | -1,187 | -959 | 518 | — |